Immune‐mediated drug‐induced liver injury secondary to Omeprazole: A case report

Omeprazole is a rare cause of DILI with autoimmune hepatitis features and should be considered when seeing patients with acute liver injury. The causative drug should be promptly identified and discontinued to avoid any permanent liver damage.

Detalles Bibliográficos
Autores principales: Seife Hassen, Sara, Ata, Fateen, Bint I Bilal, Ammara, Salih Ali, Mohamed, Petkar, Mahir, Awad Elzouki, Abdelnaser Y., Zahid, Muhammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752310/
https://www.ncbi.nlm.nih.gov/pubmed/33363945
http://dx.doi.org/10.1002/ccr3.3421
_version_ 1783625833928196096
author Seife Hassen, Sara
Ata, Fateen
Bint I Bilal, Ammara
Salih Ali, Mohamed
Petkar, Mahir
Awad Elzouki, Abdelnaser Y.
Zahid, Muhammad
author_facet Seife Hassen, Sara
Ata, Fateen
Bint I Bilal, Ammara
Salih Ali, Mohamed
Petkar, Mahir
Awad Elzouki, Abdelnaser Y.
Zahid, Muhammad
author_sort Seife Hassen, Sara
collection PubMed
description Omeprazole is a rare cause of DILI with autoimmune hepatitis features and should be considered when seeing patients with acute liver injury. The causative drug should be promptly identified and discontinued to avoid any permanent liver damage.
format Online
Article
Text
id pubmed-7752310
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-77523102020-12-23 Immune‐mediated drug‐induced liver injury secondary to Omeprazole: A case report Seife Hassen, Sara Ata, Fateen Bint I Bilal, Ammara Salih Ali, Mohamed Petkar, Mahir Awad Elzouki, Abdelnaser Y. Zahid, Muhammad Clin Case Rep Case Reports Omeprazole is a rare cause of DILI with autoimmune hepatitis features and should be considered when seeing patients with acute liver injury. The causative drug should be promptly identified and discontinued to avoid any permanent liver damage. John Wiley and Sons Inc. 2020-10-27 /pmc/articles/PMC7752310/ /pubmed/33363945 http://dx.doi.org/10.1002/ccr3.3421 Text en © 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Seife Hassen, Sara
Ata, Fateen
Bint I Bilal, Ammara
Salih Ali, Mohamed
Petkar, Mahir
Awad Elzouki, Abdelnaser Y.
Zahid, Muhammad
Immune‐mediated drug‐induced liver injury secondary to Omeprazole: A case report
title Immune‐mediated drug‐induced liver injury secondary to Omeprazole: A case report
title_full Immune‐mediated drug‐induced liver injury secondary to Omeprazole: A case report
title_fullStr Immune‐mediated drug‐induced liver injury secondary to Omeprazole: A case report
title_full_unstemmed Immune‐mediated drug‐induced liver injury secondary to Omeprazole: A case report
title_short Immune‐mediated drug‐induced liver injury secondary to Omeprazole: A case report
title_sort immune‐mediated drug‐induced liver injury secondary to omeprazole: a case report
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752310/
https://www.ncbi.nlm.nih.gov/pubmed/33363945
http://dx.doi.org/10.1002/ccr3.3421
work_keys_str_mv AT seifehassensara immunemediateddruginducedliverinjurysecondarytoomeprazoleacasereport
AT atafateen immunemediateddruginducedliverinjurysecondarytoomeprazoleacasereport
AT bintibilalammara immunemediateddruginducedliverinjurysecondarytoomeprazoleacasereport
AT salihalimohamed immunemediateddruginducedliverinjurysecondarytoomeprazoleacasereport
AT petkarmahir immunemediateddruginducedliverinjurysecondarytoomeprazoleacasereport
AT awadelzoukiabdelnasery immunemediateddruginducedliverinjurysecondarytoomeprazoleacasereport
AT zahidmuhammad immunemediateddruginducedliverinjurysecondarytoomeprazoleacasereport

Ejemplares similares